-
Technology
Flexmed has developed micro technology for membrane permeabilization to access interstitial fluid (ISF) transdermally eliminating pain, blood or skin puncture.
-
Products
Flexmed's initial transdermal sensing products are being developed for glucose monitoring of diabetes, where we can quickly help the greatest number of people.
-
Roadmap
Discovery of Flexmed's unique method for membrane permeabilization to access interstitial fluid (ISF) transdermally enables measurement of substances...
-
Management
Scientific Core, Engineering Core, Management Committee, Scientific Advisory Board
FlexMed No Needles. No Blood. No Pain.
Flexible Medical Systems has developed technology to extract interstitial fluid (ISF) for analysis without penetrating the skin.
This transdermal approach eliminates the pain, needles, and blood associated with typical blood assays.
And since the skin is not penetrated, the body's first line of defense against infection remains intact.
